Acanthamoeba Keratitis

Acanthamoeba keratitis appeared to be a relatively rare disorder with similar incidence around the world, according to a study published in Ophthalmology.

The European Commission granted marketing authorization to Akantior for the treatment of Acanthamoeba keratitis, according to a press release from Avanzanite Bioscience.

The risk for Acanthamoeba keratitis increases threefold with reusable contact lens wear compared with daily disposable lens wear, highlighting the importance of safe use guidelines, according to research in Ophthalmology.

Based on positive topline results in a pivotal phase 3 study, SIFI will pursue an accelerated assessment for polyhexanide 0.08% monotherapy to treat Acanthamoeba keratitis, according to a company press release.

A 24-year-old woman initially presented to an optometry office complaining of a red and painful left eye. She wore monthly soft contact lenses that she changed every 2 months but reported she had never slept or went swimming in them. Her symptoms started 1 day before presentation when she noted blurred vision and mild light sensitivity in her left eye. She replaced her contact lenses with a new pair without relief of her symptoms. On the day of presentation, she woke up with 8 out of 10 pain associated with tearing and photophobia.